GlassScriptPhysician profile
Donna M Muratschew
NPI 1548228851
$191.27
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $44.90 · 2021: $13.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $72.72 | 2019 | |
| Sobi, INC | $29.10 | 2019-2020 | |
| Mission Pharmacal Company | $15.98 | 2019 | |
| Adlon Therapeutics L.P. | $15.41 | 2020 | |
| Daiichi Sankyo INC. | $15.00 | 2020 | |
| Pfizer INC. | $14.93 | 2019 | |
| Cranial Technologies, INC | $14.61 | 2019 | |
| Genentech USA, INC. | $13.52 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Muratschew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.